Novartis AG
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
Last updated:
Abstract:
The present disclosure provides a compound of Formula (I'): ##STR00001## or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R.sub.1, R.sub.2, R.sub.x, X.sub.1, n, n1, and q are as defined herein, and methods of making and using same.
Status:
Application
Type:
Utility
Filling date:
5 Aug 2019
Issue date:
28 Nov 2019